Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.
暂无分享,去创建一个
R P Johnson | B. Walker | B. Korber | Steven Wolinsky | C. Brander | S. Kalams | S. Buchbinder | N. Jones | A. Trocha | R. Johnson | B Korber | S A Kalams | B D Walker | S P Buchbinder | C Brander | S Wolinsky | K E Hartman | A K Trocha | N G Jones | P Wentworth | P. Wentworth | K. Hartman | R. Johnson
[1] J. Levy,et al. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein , 1994, The Journal of experimental medicine.
[2] P. Klenerman,et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[3] H. Waldmann,et al. Limiting dilution analysis of cells of the immune system II: What can be learnt? , 1984, Immunology today.
[4] R. Sheppard,et al. Peptide synthesis. Part 2. Procedures for solid-phase synthesis using Nα-fluorenylmethoxycarbonylamino-acids on polyamide supports. Synthesis of substance P and of acyl carrier protein 65–74 decapeptide , 1981 .
[5] D. Finley,et al. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome , 1993, Nature.
[6] T. Merigan,et al. Characterization of HLA-A 0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 protein. , 1995, Journal of immunology.
[7] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[8] T. T. Wu,et al. AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.
[9] B. Walker,et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.
[10] R P Johnson,et al. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms , 1997, Journal of virology.
[11] C. Melief,et al. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. , 1996, Journal of immunology.
[12] J. Sidney,et al. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. , 1994, Molecular immunology.
[13] A. Hughes,et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] Rolf M. Zinkernagel,et al. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.
[15] R P Johnson,et al. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes , 1996, Journal of virology.
[16] A. Vitiello,et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.
[17] A. Sette,et al. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope , 1994, The Journal of experimental medicine.
[18] A. Meyerhans,et al. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. , 1995, Journal of immunology.
[19] Rainer Blasczyk,et al. Nomenclature for factors of the HLA system , 1998 .
[20] R. Sheppard,et al. PEPTIDE SYNTHESIS. PART 2. PROCEDURES FOR SOLID-PHASE SYNTHESIS USING Nα-FLUORENYLMETHOXYCARBONYL AMINO ACIDS ON POLYAMIDE SUPPORTS. SYNTHESIS OF SUBSTANCE P AND OF ACYL CARRIER PROTEIN 65-74 DECAPEPTIDE , 1981 .
[21] H. Rammensee,et al. MHC molecules as peptide receptors. , 1993, Current opinion in immunology.
[22] R. Phillips,et al. Patterns of Immunodominance in HIV-1–specific Cytotoxic T Lymphocyte Responses in Two Human Histocompatibility Leukocyte Antigens (HLA)-identical Siblings with HLA-A*0201 Are Influenced by Epitope Mutation , 1997, The Journal of experimental medicine.
[23] P. Krausa,et al. Genetic diversity of HLA-A2: evolutionary and functional significance. , 1996, Immunology today.
[24] S. Wain-Hobson,et al. The fastest genome evolution ever described: HIV variation in situ. , 1993, Current opinion in genetics & development.
[25] X. Jin,et al. Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease , 1993, The Journal of experimental medicine.
[26] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[27] Jennifer Y. Liu,et al. Hepatitis C virus infection in sexually active homosexual men. , 1994, The Journal of infection.
[28] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[29] D. Ho,et al. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope , 1994, The Journal of experimental medicine.
[30] M. Masucci,et al. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. , 1993, Science.
[31] Xiping Wei,et al. Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus , 1997, Nature Medicine.
[32] R. Young,et al. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 , 1994, The Journal of experimental medicine.
[33] C. Brander. The HLA Class I Restricted CTL Response in HIV-1 Infection : Systematic Identification of Optimal Epitopes , 1997 .
[34] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[35] B. Walker. HIV-1-Specific Cytotoxic T Lymphocytes , 1990 .
[36] R. Young,et al. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Clerici,et al. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.
[38] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[39] Steven M. Wolinsky,et al. Adaptive Evolution of Human Immunodeficiency Virus-Type 1 During the Natural Course of Infection , 1996, Science.
[40] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[41] P. Klenerman,et al. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus , 1995, European journal of immunology.
[42] J. Sissons,et al. Human cytomegalovirus‐specific cytotoxic T cells: their precursor frequency and stage specificity , 1988, European journal of immunology.
[43] B. Walker,et al. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. , 1991, Journal of immunology.
[44] S. Groth,et al. The evaluation of limiting dilution assays , 1982 .
[45] B. Walker,et al. An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[46] B. Autran,et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders , 1987, Nature.
[47] J. Coffin,et al. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.
[48] E. Rosenberg,et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.
[49] B. Walker,et al. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. , 1996, The Journal of infectious diseases.
[50] R. Koup. Virus escape from CTL recognition , 1994, The Journal of experimental medicine.
[51] W. Blattner,et al. T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant , 1996, The Journal of experimental medicine.
[52] J. Sidney,et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.
[53] A. Samri,et al. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef. , 1995, Journal of immunology.
[54] C. Brander,et al. Identification of HIV protein‐derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine , 1995, Clinical and experimental immunology.
[55] A. Hughes,et al. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. , 1992, Journal of immunology.
[57] K Eichmann,et al. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. , 1995, Immunity.
[58] H. Ploegh,et al. Substrate specificity of allelic variants of the TAP peptide transporter. , 1994, Immunity.
[59] B. Walker,et al. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire , 1994, The Journal of experimental medicine.
[60] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[61] R. Zinkernagel,et al. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[62] H. Waldmann,et al. Limiting Dilution Analysis of Cells in the Immune System , 1980 .
[63] B. Walker,et al. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. , 1988, Science.
[64] A. Meyerhans,et al. In vivo persistence of a HIV‐1‐encoded HLA‐B27‐restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity , 1991, European journal of immunology.